BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30995217)

  • 1. Predicting synthetic lethal interactions using conserved patterns in protein interaction networks.
    Benstead-Hume G; Chen X; Hopkins SR; Lane KA; Downs JA; Pearl FMG
    PLoS Comput Biol; 2019 Apr; 15(4):e1006888. PubMed ID: 30995217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SL
    Liu Y; Wu M; Liu C; Li XL; Zheng J
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
    Srivas R; Shen JP; Yang CC; Sun SM; Li J; Gross AM; Jensen J; Licon K; Bojorquez-Gomez A; Klepper K; Huang J; Pekin D; Xu JL; Yeerna H; Sivaganesh V; Kollenstart L; van Attikum H; Aza-Blanc P; Sobol RW; Ideker T
    Mol Cell; 2016 Aug; 63(3):514-25. PubMed ID: 27453043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synthetic lethal pairs in biological systems through network information centrality.
    Kranthi T; Rao SB; Manimaran P
    Mol Biosyst; 2013 Aug; 9(8):2163-7. PubMed ID: 23728082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting disease genes based on semi-supervised learning and protein-protein interaction networks.
    Nguyen TP; Ho TB
    Artif Intell Med; 2012 Jan; 54(1):63-71. PubMed ID: 22000346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of synthetic lethality based on a functional network by using machine learning algorithms.
    Li J; Lu L; Zhang YH; Liu M; Chen L; Huang T; Cai YD
    J Cell Biochem; 2019 Jan; 120(1):405-416. PubMed ID: 30125975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Lethality and Cancer - Penetrance as the Major Barrier.
    Ryan CJ; Bajrami I; Lord CJ
    Trends Cancer; 2018 Oct; 4(10):671-683. PubMed ID: 30292351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions.
    Lord CJ; Quinn N; Ryan CJ
    Elife; 2020 May; 9():. PubMed ID: 32463358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.
    Shen JP; Ideker T
    J Mol Biol; 2018 Sep; 430(18 Pt A):2900-2912. PubMed ID: 29932943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility.
    Ku AA; Hu HM; Zhao X; Shah KN; Kongara S; Wu D; McCormick F; Balmain A; Bandyopadhyay S
    Nat Commun; 2020 May; 11(1):2375. PubMed ID: 32398776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
    Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
    Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in-silico approach to predict and exploit synthetic lethality in cancer metabolism.
    Apaolaza I; San José-Eneriz E; Tobalina L; Miranda E; Garate L; Agirre X; Prósper F; Planes FJ
    Nat Commun; 2017 Sep; 8(1):459. PubMed ID: 28878380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise Characterization of Genetic Interactions in Cancer via Molecular Network Refining Processes.
    Jung J; Hwang Y; Ahn H; Lee S; Yoo S
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
    Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
    Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
    Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
    Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal control nodes in disease-perturbed networks as targets for combination therapy.
    Hu Y; Chen CH; Ding YY; Wen X; Wang B; Gao L; Tan K
    Nat Commun; 2019 May; 10(1):2180. PubMed ID: 31097707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting genetic interactions with random walks on biological networks.
    Chipman KC; Singh AK
    BMC Bioinformatics; 2009 Jan; 10():17. PubMed ID: 19138426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic lethality in large-scale integrated metabolic and regulatory network models of human cells.
    Barrena N; Valcárcel LV; Olaverri-Mendizabal D; Apaolaza I; Planes FJ
    NPJ Syst Biol Appl; 2023 Jul; 9(1):32. PubMed ID: 37454223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery.
    Fadhal E; Mwambene EC; Gamieldien J
    BMC Syst Biol; 2014 Jun; 8():68. PubMed ID: 24929653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase A, a synthetic lethal target for precision cancer medicine.
    Mou PK; Yang EJ; Shi C; Ren G; Tao S; Shim JS
    Exp Mol Med; 2021 May; 53(5):835-847. PubMed ID: 34050264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.